Neurological disorders and neuro oncology impose a growing clinical and societal burden, while therapeutic development remains slow, costly, and uncertain.

Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping ...

A landmark NIH-funded research initiative has produced the first comprehensive map of aging cells across the human body, ...

A growing body of experimental research in mice, combined with early human cohort data, points to a striking possibility: the ...

Integrated Systems Biology and Genomics have fundamentally changed how cancer research progresses. Cancer is a disease of dysregulated systems — tumors ...

In this edition of the biotech bi-weekly, catch up on five innovative product launches – from lab balances to spatial solutions – and recent partnerships driving human health forward. Illumina (CA, ...

By analyzing brain tissue at single-cell resolution, researchers identified biological pathways that separate Alzheimer’s ...

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of ...

A new study discovers a critical microglial cell transition that determines whether Alzheimer’s pathology causes dementia.

ASMS 2026 highlighted AI-driven MS software, faster/deeper proteomics, spatial biology imaging, biopharma characterization tools, PFAS monitoring, and greener instrumentation. Artificial intelligence ...